Help Center

 Thalassemia is highly prevalent in India, with approximately 1 to 1.5 lakh children diagnosed with Thalassemia major worldwide. Around 42 million individuals are carriers of the ß (beta) thalassemia trait, and every year, 10,000 to 15,000 babies are born with Thalassemia major. 

Thalassemia testing offers several benefits, including early detection of carriers, preventing transmission to future generations, and enabling informed decisions for carriers planning their future. 

Sterling Accuris offers a comprehensive range of thalassemia tests, including screening tests such as CBC and HB electrophoresis, and confirmatory tests like ß-thalassemia and alpha thalassemia testing using Sanger sequencing, along with additional analysis for maternal cell contamination. These tests aid in the accurate diagnosis and management of thalassemia.